Home Interviews How Magle Group focus their use of DSM

How Magle Group focus their use of DSM

Magle Group

How Magle Group focus their use of DSM

21 August, 2024

The company aims to establish itself as a leader in life-changing healthcare innovations. Watch Justin Pierce, CEO and Helena Ossmer Thedius, Chief Marketing and Innovation Officer, explain their technology platform of degradable starch microspheres (DSM), serving as the base for development of new products, in BioStock Studio.

YouTube video

The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.

Prenumerera på BioStocks nyhetsbrev